Ramiven 200mg (Abemaciclib Tablet) 200mg

Ramiven 200mg (Abemaciclib) is a prescription tablet used for certain breast cancers. It belongs to the CDK4/6 inhibitor class and is taken orally. This 200mg strength comes in a 14-tablet pack for convenient dosing. Always follow healthcare provider instructions when using this medication.

Strength

200mg

Pack Size

14s

Storage

Ambient

Manufacturer / TM Owner

Lilly S.A

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ramiven 200mg (Abemaciclib) is prescribed to treat advanced or metastatic hormone receptor-positive, HER2-negative breast cancer in adults. It is often used in combination with hormone therapy or as monotherapy when hormone therapy is not suitable. This medication works by blocking proteins that drive cancer cell growth. It is not a chemotherapy drug but targets specific pathways in cancer progression.

Side Effects

Ramiven 200mg (Abemaciclib) may cause fatigue, nausea, or diarrhea as common effects. Some users report decreased appetite or abdominal discomfort during treatment. Hair thinning or changes in blood cell counts may also occur. These effects vary by individual and should be monitored by a healthcare professional.

Precautions & Warnings

Store Ramiven 200mg (Abemaciclib) at room temperature away from moisture and heat. Keep out of reach of children and pets. Inform your doctor about all medications and supplements you take before starting this treatment. Regular blood tests may be needed to check for side effects during therapy.

Avoid Interactions

Ramiven 200mg (Abemaciclib) may interact with strong CYP3A inhibitors or inducers, affecting its effectiveness. Grapefruit products can increase side effects and should be avoided. Hormonal contraceptives may interact with this medication; consult your doctor about alternative birth control methods. Always disclose all prescription, over-the-counter, and herbal products to your healthcare provider.

Frequently Asked Questions

Ramiven 200mg (Abemaciclib) is used to treat advanced hormone receptor-positive, HER2-negative breast cancer in adults.

Ramiven 200mg is taken orally as directed by a healthcare provider, usually twice daily with or without food.

Common side effects include fatigue, nausea, diarrhea, decreased appetite, and changes in blood cell counts.

It is not recommended to consume grapefruit or grapefruit juice while taking Ramiven 200mg due to potential interactions.

No, Ramiven 200mg (Abemaciclib) is not a chemotherapy drug; it belongs to the CDK4/6 inhibitor class.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.